{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:56:01Z","timestamp":1790621761269,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T00:00:00Z","timestamp":1439251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s11255-015-1074-1","type":"journal-article","created":{"date-parts":[[2015,8,9]],"date-time":"2015-08-09T21:54:32Z","timestamp":1439157272000},"page":"1595-1602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Intralesional hyaluronic acid: an innovative treatment for Peyronie\u2019s disease"],"prefix":"10.1007","volume":"47","author":[{"given":"Romano","family":"Gennaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Paulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,11]]},"reference":[{"key":"1074_CR1","first-page":"425","volume":"1","author":"F Peyronie La","year":"1743","unstructured":"La Peyronie F (1743) Sur quelques obstacles qui s\u00f3pposent \u00e0 l\u2019\u00e9jaculation naturelle de la semence. Mem Acad Royale Chir 1:425\u2013439","journal-title":"Mem Acad Royale Chir"},{"key":"1074_CR2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","volume":"88","author":"U Schwarzer","year":"2001","unstructured":"Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U (2001) The prevalence of Peyronie\u2019s disease: results of a large survey. BJU Int 88:727\u2013730","journal-title":"BJU Int"},{"key":"1074_CR3","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","volume":"171","author":"JP Mulhall","year":"2004","unstructured":"Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, Davis R et al (2004) Subjective and objective analysis of the prevalence of Peyronie\u2019s disease in a population of men presenting for prostate cancer screening. J Urol 171:2350\u20132353","journal-title":"J Urol"},{"key":"1074_CR4","doi-asserted-by":"crossref","unstructured":"Dibenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou XA (2011) Population-based study of Peyronie\u2019s Disease: prevalence and treatment patterns in the United States. Adv Urol. Article ID 282503. Published online 2011. doi: 10.1155\/2011\/282503 . Available at: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3202120\/pdf\/AU2011-282503.pdf","DOI":"10.1155\/2011\/282503"},{"issue":"5","key":"1074_CR5","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/j.1743-6109.2012.02704.x","volume":"9","author":"GH Dolmans","year":"2012","unstructured":"Dolmans GH, Werker PM, de Jong IJ, Nijman RJ, LifeLines Cohort Study, Wijmenga C et al (2012) WNT2 locus is involved in genetic susceptibility of Peyronie\u2019s disease. J Sex Med 9(5):1430\u20131434","journal-title":"J Sex Med"},{"issue":"4 Pt 1","key":"1074_CR6","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.ju.0000076488.89748.e1","volume":"170","author":"EW Hauck","year":"2003","unstructured":"Hauck EW, Hauptmann A, Weidner W, Bein G, Hackstein H (2003) Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie\u2019s disease. J Urol 170(4 Pt 1):1443\u20131446","journal-title":"J Urol"},{"issue":"5","key":"1074_CR7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0090-4295(97)00333-6","volume":"50","author":"D Schiavino","year":"1997","unstructured":"Schiavino D, Sasso F, Nucera E, Alcini E, Gulino G, Milani A et al (1997) Immunologic findings in Peyronie\u2019s disease: a controlled study. Urology 50(5):764\u2013768","journal-title":"Urology"},{"issue":"1","key":"1074_CR8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-5347(17)32828-8","volume":"152","author":"S Stewart","year":"1994","unstructured":"Stewart S, Malto M, Sandberg L, Colburn KK (1994) Increased serum levels of anti-elastin antibodies in patients with Peyronie\u2019s disease. J Urol 152(1):105\u2013106","journal-title":"J Urol"},{"key":"1074_CR9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-5347(01)65361-8","volume":"157","author":"CJ Devine Jr","year":"1997","unstructured":"Devine CJ Jr, Somers KD, Jordan GH, Schlossberg SM (1997) Proposal: trauma as the cause of the Peyronie\u2019s lesion. J Urol 157:285\u2013290","journal-title":"J Urol"},{"issue":"5","key":"1074_CR10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/18715281113129990055","volume":"12","author":"G Paulis","year":"2013","unstructured":"Paulis G, Cavallini G (2013) Clinical evaluation of natural history of Peyronie\u2019s disease: our experience, old myths and new certainties. Inflamm Allergy Drug Targets 12(5):341\u2013348","journal-title":"Inflamm Allergy Drug Targets"},{"key":"1074_CR11","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","volume":"175","author":"JP Mulhall","year":"2006","unstructured":"Mulhall JP, Schiff J, Guhring P (2006) An analysis of the natural history of Peyronie\u2019s disease. J Urol 175:2115\u20132118","journal-title":"J Urol"},{"key":"1074_CR12","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","volume":"144","author":"MK Gelbard","year":"1990","unstructured":"Gelbard MK, Dorey F, James K (1990) The natural history of Peyronie\u2019s disease. J Urol 144:1376\u20131379","journal-title":"J Urol"},{"key":"1074_CR13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.eururo.2006.02.059","volume":"49","author":"EW Hauck","year":"2006","unstructured":"Hauck EW, Diemer T, Schmelz HU, Weidner W (2006) A critical analysis of nonsurgical treatment of Peyronie\u2019s disease. Eur Urol 49:987\u2013997","journal-title":"Eur Urol"},{"issue":"1","key":"1074_CR14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jsm.12731","volume":"12","author":"LA Levine","year":"2015","unstructured":"Levine LA, Cuzin B, Mark S, Gelbard MK, Jones NA, Liu G et al (2015) Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie\u2019s disease: a phase 3 open-label study. J Sex Med 12(1):248\u2013258","journal-title":"J Sex Med"},{"key":"1074_CR15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-410X.2009.09041.x","volume":"106","author":"MR Safarinejad","year":"2010","unstructured":"Safarinejad MR, Asgari MA, Hosseini SY, Dadkhah F (2010) A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie\u2019s disease. BJU Int 106:240\u2013248","journal-title":"BJU Int"},{"key":"1074_CR16","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.juro.2007.05.162","volume":"178","author":"MR Safarinejad","year":"2007","unstructured":"Safarinejad MR, Hosseini SY, Kolahi AA (2007) Comparison of vitamin E and propionyl-l-carnitine, separately or in combination, in patients with early chronic Peyronie\u2019s disease: a double-blind, placebo controlled, randomized study. J Urol 178:1398\u20131403","journal-title":"J Urol"},{"issue":"3","key":"1074_CR17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","volume":"62","author":"K Hatzimouratidis","year":"2012","unstructured":"Hatzimouratidis K, Eardley I, Giuliano F, Hatzichristou D, Moncada I, Salonia A et al (2012) EAU guidelines on penile curvature. Eur Urol 62(3):543\u2013552","journal-title":"Eur Urol"},{"issue":"1","key":"1074_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J et al (2013) Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol 190(1):199\u2013207","journal-title":"J Urol"},{"key":"1074_CR19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00042307-200411000-00015","volume":"14","author":"M Kendirci","year":"2004","unstructured":"Kendirci M, Hellstrom WJ (2004) Critical analysis of surgery for Peyronie\u2019s disease. Curr Opin Urol 14:381\u2013388","journal-title":"Curr Opin Urol"},{"issue":"2","key":"1074_CR20","first-page":"103","volume":"1","author":"D Irani","year":"2004","unstructured":"Irani D, Zeighami SH, Khezri AA (2004) Results of dermal patch graft in the treatment of Peyronie\u2019s disease. Urol J 1(2):103\u2013106","journal-title":"Urol J"},{"issue":"2","key":"1074_CR21","first-page":"99","volume":"1","author":"MR Nikoobakht","year":"2004","unstructured":"Nikoobakht MR, Mehrsai A, Pourmand GH, Jaladat H, Nasseh HR (2004) Management of Peyronie\u2019s disease by dermal grafting. Urol J. 1(2):99\u2013102","journal-title":"Urol J."},{"issue":"4","key":"1074_CR22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.phrs.2006.06.002","volume":"54","author":"E Karna","year":"2006","unstructured":"Karna E, Miltyk W, Pa\u0142ka JA, Jarzabek K, Wo\u0142czy\u0144ski S (2006) Hyaluronic acid counteracts interleukin-1-induced inhibition of collagen biosynthesis in cultured human chondrocytes. Pharmacol Res 54(4):275\u2013281","journal-title":"Pharmacol Res"},{"issue":"5","key":"1074_CR23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.phrs.2004.12.002","volume":"51","author":"P Nawrat","year":"2005","unstructured":"Nawrat P, Surazy\u0144ski A, Karna E, Pa\u0142ka JA (2005) The effect of hyaluronic acid on interleukin-1-induced deregulation of collagen metabolism in cultured human skin fibroblasts. Pharmacol Res 51(5):473\u2013477","journal-title":"Pharmacol Res"},{"issue":"2","key":"1074_CR24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000019698","volume":"34","author":"R Andresen","year":"1998","unstructured":"Andresen R, Wegner HE, Miller K, Banzer D (1998) Imaging modalities in Peyronie\u2019s disease. An intrapersonal comparison of ultrasound sonography, X-ray in mammography technique, computerized tomography, and nuclear magnetic resonance in 20 patients. Eur Urol 34(2):128\u2013134 (discussion 135)","journal-title":"Eur Urol"},{"key":"1074_CR25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0090-4295(83)90210-8","volume":"21","author":"A Kel\u00e2mi","year":"1983","unstructured":"Kel\u00e2mi A (1983) Autophotography in evaluation of functional penile disorders. Urology 21:628\u2013629","journal-title":"Urology"},{"key":"1074_CR26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7863\/jum.2009.28.2.217","volume":"28","author":"D Prando","year":"2009","unstructured":"Prando D (2009) New sonographic aspects of peyronie disease. J Ultrasound Med 28:217\u2013232","journal-title":"J Ultrasound Med"},{"key":"1074_CR27","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","volume":"49","author":"RC Rosen","year":"1997","unstructured":"Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishrs A (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822\u2013830","journal-title":"Urology"},{"key":"1074_CR28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","volume":"94","author":"JT Farrar","year":"2001","unstructured":"Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149\u2013158","journal-title":"Pain"},{"issue":"7","key":"1074_CR29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2174\/1874325001307010378","volume":"20","author":"HK Vincent","year":"2013","unstructured":"Vincent HK, Percival SS, Conrad BP, Seay AN, Montero C, Vincent KR (2013) Hyaluronic Acid (HA) viscosupplementation on synovial fluid inflammation in knee osteoarthritis: a pilot study. Open Orthop J 20(7):378\u2013384","journal-title":"Open Orthop J"},{"issue":"10","key":"1074_CR30","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.fct.2011.07.020","volume":"49","author":"C Ke","year":"2011","unstructured":"Ke C, Sun L, Qiao D, Wang D, Zeng X (2011) Antioxidant acitivity of low molecular weight hyaluronic acid. Food Chem Toxicol 49(10):2670\u20132675","journal-title":"Food Chem Toxicol"},{"key":"1074_CR31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/187152812798889321","volume":"11","author":"G Paulis","year":"2012","unstructured":"Paulis G, Brancato T (2012) Inflammatory mechanisms and oxidative stress in Peyronie\u2019s disease. Therapeutic \u201crationale\u201d and related emerging treatment strategies. Inflamm Allergy Drug Targets 11:48\u201357","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"6","key":"1074_CR32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/sj.ijir.3901058","volume":"15","author":"DG Moon","year":"2003","unstructured":"Moon DG, Kwak TI, Cho HY, Bae JH, Park HS, Kim JJ (2003) Augmentation of glans penis using injectable hyaluronic acid gel. Int J Impot Res 15(6):456\u2013460","journal-title":"Int J Impot Res"},{"issue":"6","key":"1074_CR33","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.juro.2013.05.022","volume":"190","author":"LW Trost","year":"2013","unstructured":"Trost LW, Ates E, Powers M, Sikka S, Hellstrom WJ (2013) Outcomes of intralesional interferon-\u03b12B for the treatment of Peyronie disease. J Urol 190(6):2194\u20132199","journal-title":"J Urol"},{"key":"1074_CR34","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1111\/j.1743-6109.2010.01924.x","volume":"7","author":"J Soh","year":"2010","unstructured":"Soh J, Kawauchi A, Kanemitsu N, Naya Y, Ochiai A, Naitoh Y et al (2010) Nicardipine vs. saline injection as treatment for Peyronie disease: a prospective, randomized, single-blind trial. J Sex Med 7:3743\u20133749","journal-title":"J Sex Med"},{"issue":"1","key":"1074_CR35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11255-008-9408-x","volume":"41","author":"C Tuygun","year":"2009","unstructured":"Tuygun C, Ozok UH, Gucuk A, Bozkurt IH, Imamoglu MA (2009) The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie\u2019s disease. Int Urol Nephrol 41(1):113\u2013118","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"1074_CR36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1743-6109.2006.00417.x","volume":"4","author":"WP Fitch 3rd","year":"2007","unstructured":"Fitch WP 3rd, Easterling WJ, Talbert RL, Bordovsky MJ, Mosier M (2007) Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie\u2019s disease\u2014a placebo-controlled pilot study. J Sex Med 4(2):477\u2013484","journal-title":"J Sex Med"},{"issue":"6","key":"1074_CR37","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","volume":"69","author":"NE Bennett","year":"2007","unstructured":"Bennett NE, Guhring P, Mulhall JP (2007) Intralesional verapamil prevents the progression of Peyronie\u2019s disease. Urology 69(6):1181\u20131184","journal-title":"Urology"},{"issue":"1","key":"1074_CR38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1743-6109.2007.00651.x","volume":"5","author":"GH Jordan","year":"2008","unstructured":"Jordan GH (2008) The use of intralesional clostridial collagenase injection therapy for Peyronie\u2019s disease: a prospective, single-center, non-placebo-controlled study. J Sex Med 5(1):180\u2013187","journal-title":"J Sex Med"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1074-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-015-1074-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1074-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T01:38:16Z","timestamp":1567042696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-015-1074-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,11]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1074"],"URL":"https:\/\/doi.org\/10.1007\/s11255-015-1074-1","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,11]]}}}